Annual Drug Patent Expirations for REQUIP+XL Requip Xl is a drug marketed by Glaxosmithkline Llc and is included in one NDA. There are two patents protecting this drug and seven…
The post New patent expiration for Glaxosmithkline Llc drug REQUIP XL app…
New patent expiration for Glaxosmithkline Llc drug REQUIP XL Read Post »
FLOVENT HFA (fluticasone propionate) Glaxo grp ltd Patent: 6,743,413 Expiration: Dec 1, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations for the…
Drug Patent Expirations for the Week of November 28, 2021 Read Post »
Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from four suppliers. There are…
The post New patent expiration for Glaxo Grp drug FLOVENT HFA appeared first on D…
New patent expiration for Glaxo Grp drug FLOVENT HFA Read Post »
Annual Drug Patent Expirations for NAVSTEL Navstel is a drug marketed by Alcon Pharms Ltd and is included in one NDA. There is one patent protecting this drug. This drug…
The post New patent expiration for Alcon Pharms drug NAVSTEL appeared first on Dr…
New patent expiration for Alcon Pharms drug NAVSTEL Read Post »
Annual Drug Patent Expirations for OZURDEX Ozurdex is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent expiration for Allergan drug OZURDEX appeared first…
Annual Drug Patent Expirations for CALDOLOR Caldolor is a drug marketed by Cumberland Pharms and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent expiration for Cumberland Pharms drug CALDOLOR appear…
New patent expiration for Cumberland Pharms drug CALDOLOR Read Post »
Annual Drug Patent Expirations for CHILDREN%27S+ALLEGRA+ALLERGY For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
The post New p…
New patent expiration for Sanofi Aventis drug CHILDREN’S ALLEGRA ALLERGY Read Post »
Annual Drug Patent Expirations for CHILDREN%27S+ALLEGRA+HIVES For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
The post New pat…
New patent expiration for Sanofi Aventis drug CHILDREN’S ALLEGRA HIVES Read Post »
Annual Drug Patent Expirations for SELZENTRY Selzentry is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from one supplier. There are three patents…
The post New patent expiration for Viiv Hlthcare drug SELZENTRY appeared…
New patent expiration for Viiv Hlthcare drug SELZENTRY Read Post »
Annual Drug Patent Expirations for PROMACTA Promacta is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are twelve patents protecting…
The post New patent expiration for Novartis drug PROMACTA appeared …
New patent expiration for Novartis drug PROMACTA Read Post »